![Markus Renschler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus Renschler
Presidente presso
CYTEIR THERAPEUTICS, INC.
Profilo
Markus F.
Renschler is President & Director at Cyteir Therapeutics, Inc. since 2018.
Former roles include Senior Vice President & Global Head-Hematology at Celgene Corp., Senior VP-Oncology Clinical Development at Pharmacyclics LLC from 1996 to 2007, Vice President-Clinical Development at Pharmion Corp.
from 2007 to 2008, Associate Professor at Stanford University, and Chief Medical Officer & Senior Vice President at Celgene Cellular Therapeutics from 2008 to 2017.
Education includes a doctorate from Stanford University and an undergraduate degree from Princeton University.
Posizioni attive di Markus Renschler
| Società | Posizione | Inizio |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Presidente | 01/01/2018 |
Precedenti posizioni note di Markus Renschler
| Società | Posizione | Fine |
|---|---|---|
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Direttore Tecnico/Scientifico/R&S | 01/01/2017 |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2015 |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Direttore Tecnico/Scientifico/R&S | 01/01/2008 |
| PHARMACYCLICS, INC. | Direttore Tecnico/Scientifico/R&S | 28/12/2007 |
| CELGENE | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Markus Renschler
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
21
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company | Health Technology |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Develops human pharmaceuticals | Health Technology |
